[HTML][HTML] Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
[HTML][HTML] Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
S Katoch, V Sharma, V Patial - World Journal of Gastroenterology, 2022 - wjgnet.com
Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
S Katoch, V Sharma, V Patial - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
[PDF][PDF] WJG
S Katoch, V Sharma, V Patial, YG Li, ZJ Yu, A Li… - World J …, 2022 - pure.eur.nl
Hepatocellular carcinoma (HCC) is among the most common cancers and it is a major
cause of cancer-related deaths. Non-alcoholic fatty liver disease (NAFLD) affects …
cause of cancer-related deaths. Non-alcoholic fatty liver disease (NAFLD) affects …
[PDF][PDF] WJG
S Katoch, V Sharma, V Patial, YG Li, ZJ Yu, A Li… - World J …, 2022 - core.ac.uk
Acute liver failure (ALF) is a severe and life-threatening condition in which rapid
deterioration of liver function develops in a patient who has no preexisting liver disease …
deterioration of liver function develops in a patient who has no preexisting liver disease …
[PDF][PDF] WJG
S Katoch, V Sharma, V Patial, YG Li, ZJ Yu… - World J …, 2022 - scholar.archive.org
Acute liver failure (ALF) is a severe and life-threatening condition in which rapid
deterioration of liver function develops in a patient who has no preexisting liver disease …
deterioration of liver function develops in a patient who has no preexisting liver disease …
[PDF][PDF] WJG
S Katoch, V Sharma, V Patial, YG Li, ZJ Yu… - World J …, 2022 - researchgate.net
Acute liver failure (ALF) is a severe and life-threatening condition in which rapid
deterioration of liver function develops in a patient who has no preexisting liver disease …
deterioration of liver function develops in a patient who has no preexisting liver disease …
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios.
S Katoch, V Sharma, V Patial - World Journal of Gastroenterology, 2022 - europepmc.org
Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …
Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios
S Katoch, V Sharma, V Patial - World Journal of Gastroenterology, 2022 - wjgnet.com
Figure 1 General structure and ligand-activated transcription of peroxisome proliferator-
activated receptor-gamma. A: Peroxisome proliferator-activated receptor (PPAR) structure …
activated receptor-gamma. A: Peroxisome proliferator-activated receptor (PPAR) structure …
[PDF][PDF] WJG
S Katoch, V Sharma, V Patial, YG Li, ZJ Yu, A Li… - World J …, 2022 - pure.eur.nl
Hepatocellular carcinoma (HCC) is among the most common cancers and it is a major
cause of cancer-related deaths. Non-alcoholic fatty liver disease (NAFLD) affects …
cause of cancer-related deaths. Non-alcoholic fatty liver disease (NAFLD) affects …